BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32839217)

  • 21. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
    Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
    Trials; 2016 Mar; 17():170. PubMed ID: 27029920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
    Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with β-lactam antibiotics in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections.
    Ye C; Wang Z; Hu Y; Deng C; Liao L; Sun L; Wang C
    J Glob Antimicrob Resist; 2020 Dec; 23():303-310. PubMed ID: 33045437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
    Moise PA; Amodio-Groton M; Rashid M; Lamp KC; Hoffman-Roberts HL; Sakoulas G; Yoon MJ; Schweitzer S; Rastogi A
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1192-200. PubMed ID: 23254428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function.
    Weston A; Golan Y; Holcroft C; Snydman DR
    Clin Infect Dis; 2014 Jun; 58(11):1533-9. PubMed ID: 24642554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
    Chuang YC; Wang JT; Yang JL; Lin CY; Huang SH; Chen YC; Chang SC
    J Infect Public Health; 2022 Dec; 15(12):1396-1402. PubMed ID: 36371936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
    Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
    J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
    Dhand A; Sakoulas G
    Clin Ther; 2014 Oct; 36(10):1303-16. PubMed ID: 25444563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
    Wong D; Wong T; Romney M; Leung V
    BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
    Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
    Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Wilsey HA; Burgess DR; Burgess DS
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis.
    Grillo S; Cuervo G; Carratalà J; Grau I; Pallarès N; Tebé C; Guillem Tió L; Murillo O; Ardanuy C; Domínguez MA; Shaw E; Gudiol C; Pujol M
    Clin Infect Dis; 2019 Oct; 69(9):1480-1488. PubMed ID: 30615122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli.
    Morrisette T; Lagnf AM; Alosaimy S; Rybak MJ
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2199-2203. PubMed ID: 32535805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
    Holubar M; Meng L; Deresinski S
    Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis.
    Ishaq H; Tariq W; Talha KM; Palraj BRV; Sohail MR; Baddour LM; Mahmood M
    Infection; 2021 Oct; 49(5):803-811. PubMed ID: 33394368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methicillin-resistant Staphylococcus aureus infections: role of daptomycin/β-lactams combination.
    Leone S; Noviello S; Boccia G; De Caro F; Esposito S
    Infez Med; 2015 Jun; 23(2):99-104. PubMed ID: 26110289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.